These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10333379)

  • 1. Neurophysiologic predictors of treatment response to fluoxetine in major depression.
    Cook IA; Leuchter AF; Witte E; Abrams M; Uijtdehaage SH; Stubbeman W; Rosenberg-Thompson S; Anderson-Hanley C; Dunkin JJ
    Psychiatry Res; 1999 Mar; 85(3):263-73. PubMed ID: 10333379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.
    Bares M; Brunovsky M; Kopecek M; Stopkova P; Novak T; Kozeny J; Höschl C
    J Psychiatr Res; 2007; 41(3-4):319-25. PubMed ID: 16889798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern analysis of antidepressant response to fluoxetine.
    Fieve RR; Goodnick PJ; Peselow ED; Barouche F; Schlegel A
    J Clin Psychiatry; 1986 Nov; 47(11):560-2. PubMed ID: 3533909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in brain function of depressed subjects during treatment with placebo.
    Leuchter AF; Cook IA; Witte EA; Morgan M; Abrams M
    Am J Psychiatry; 2002 Jan; 159(1):122-9. PubMed ID: 11772700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression.
    Leuchter AF; Morgan M; Cook IA; Dunkin J; Abrams M; Witte E
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):15-22. PubMed ID: 15252704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The change of QEEG prefrontal cordance as a response predictor to antidepressive intervention in bipolar depression. A pilot study.
    Bares M; Novak T; Brunovsky M; Kopecek M; Stopkova P; Krajca V; Höschl C
    J Psychiatr Res; 2012 Feb; 46(2):219-25. PubMed ID: 21937059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder.
    Hunter AM; Muthén BO; Cook IA; Leuchter AF
    J Psychiatr Res; 2010 Jan; 44(2):90-8. PubMed ID: 19631948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
    Zajecka JM; Jeffries H; Fawcett J
    J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of physical illness on quality of life and antidepressant response in geriatric major depression. Fluoxetine Collaborative Study Group.
    Small GW; Birkett M; Meyers BS; Koran LM; Bystritsky A; Nemeroff CB
    J Am Geriatr Soc; 1996 Oct; 44(10):1220-5. PubMed ID: 8856002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early changes in prefrontal activity characterize clinical responders to antidepressants.
    Cook IA; Leuchter AF; Morgan M; Witte E; Stubbeman WF; Abrams M; Rosenberg S; Uijtdehaage SH
    Neuropsychopharmacology; 2002 Jul; 27(1):120-31. PubMed ID: 12062912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia.
    Hellerstein DJ; Yanowitch P; Rosenthal J; Samstag LW; Maurer M; Kasch K; Burrows L; Poster M; Cantillon M; Winston A
    Am J Psychiatry; 1993 Aug; 150(8):1169-75. PubMed ID: 8328559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.
    Emslie GJ; Rush AJ; Weinberg WA; Kowatch RA; Hughes CW; Carmody T; Rintelmann J
    Arch Gen Psychiatry; 1997 Nov; 54(11):1031-7. PubMed ID: 9366660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine treatment of dysthymia in the elderly.
    Nobler MS; Devanand DP; Kim MK; Fitzsimons LM; Singer TM; Turret N; Sackeim HA; Roose SP
    J Clin Psychiatry; 1996 Jun; 57(6):254-6. PubMed ID: 8666563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of acupuncture and fluoxetine for depression: a randomized, double-blind, sham-controlled trial.
    Zhang WJ; Yang XB; Zhong BL
    J Altern Complement Med; 2009 Aug; 15(8):837-44. PubMed ID: 19678773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men.
    Bruder GE; Stewart JW; McGrath PJ; Deliyannides D; Quitkin FM
    Neuropsychopharmacology; 2004 Sep; 29(9):1752-61. PubMed ID: 15238992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does prior antidepressant treatment of major depression impact brain function during current treatment?
    Hunter AM; Cook IA; Leuchter AF
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):711-20. PubMed ID: 22445212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.